Pharma
44.6K views | +1 today
Follow
Pharma
Curating the writing of pharma's digital prescription
Curated by Andrew Spong
Your new post is loading...
Your new post is loading...
Scooped by Andrew Spong
Scoop.it!

The top 20 pharma app makers

The top 20 pharma app makers | Pharma | Scoop.it

The medical app market is dominated by the big players, since they have the resources to create the best apps and the financial muscle to push their products in the market.

 

The lion’s share of the medical apps market is occupied by established companies with historically strong brands. Bayer leads the pack with 11.2% market share, followed closely by Merck, Novartis, Pfizer, and Boehringer Ingelheim

more...
Paulo Machado's curator insight, July 9, 2014 11:14 AM

How about a measure of health impact of these apps?  As BioPharma(& other corps) move into health apps shouldn't they be measuring Benefits/Risks like is done with Medicine?

Scooped by Andrew Spong
Scoop.it!

42 percent of pharma companies are increasing spending on patient-oriented comms in 2014

more...
Bettina Gifford's curator insight, July 3, 2014 5:35 PM
Www.hcpmeetings.com.au can let your HCPs know about your programs plus meetings...
Scooped by Andrew Spong
Scoop.it!

Looking beyond patient engagement for pharma and social media

Looking beyond patient engagement for pharma and social media | Pharma | Scoop.it

Mark Senak (@EyeonFDA) writes:

 

"Twitter is the medium for reporting news and at medical meetings there is a lot of news to report, and hence, a good deal to follow.  Reporters, scientists, physicians, patient groups are all commenting and reporting on what they are seeing and hearing that is of interest at meetings and the increase in twitter use at medical meetings from year to year is huge, with particular increases reported for the ASCO and ASH meetings.

 

This is also whypharma web sites (and medical society websties) need to be optimized for mobile,because people aren’t walking around medical meetings using their laptops – they are on their phones."

 

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Pharma's role in the digital health landscape

Pharma's role in the digital health landscape | Pharma | Scoop.it
more...
malek's curator insight, May 14, 2014 11:30 AM

The health costs, access and resources are a key driver to seeking solutions to the health dilemma that exists right now and is projected to only get worse.  

Scooped by Andrew Spong
Scoop.it!

Followers of healthcare companies: an infographic

Followers of healthcare companies: an infographic | Pharma | Scoop.it
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Surveying the therapeutic areas pharma participates in on facebook, YouTube and Pinterest

Surveying the therapeutic areas pharma participates in on facebook, YouTube and Pinterest | Pharma | Scoop.it

Many companies have created online forums as support networks for patients and their loved ones. Customized online communities can greatly impact patients, but many of these support groups can also be found on mainstream platforms like Facebook.


The article show popular therapeutic areas that are represented on pharma-sponsored Facebook, YouTube and Pinterest sites, according to secondary research conducted by CEI analysts.


In these graphics, the larger the circle, the larger a presence the therapeutic area has on the social media platform. These data suggest that central nervous system (CNS), diabetes and oncology patients have many options for online support. But there are also options for endocrinology, respiratory and immunology patients – to only name a few.

 

Facebook is shown above.

 

YouTube: http://www.cuttingedgeinfo.com/wp/wp-content/uploads/Figure-2-YouTube-TA-presence-JPEG-400x299.jpg

 

Pinterest: http://www.cuttingedgeinfo.com/wp/wp-content/uploads/Figure-3-Pinterest-TA-presence-JPEG-400x300.jpg

 

 

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Pharma's current business model 'does not put the patient at the heart of its decision-making', says KPMG

Pharma's current business model 'does not put the patient at the heart of its decision-making', says KPMG | Pharma | Scoop.it

Pharmaceutical companies need to stop simply paying lip-service to patients and radically alter their business models if they are to meet increasing global demand while improving patient outcomes, says KPMG.

more...
rob halkes's curator insight, April 16, 2014 5:03 AM

Indeed the pharma model needs to be build on an comprehensive view on pharma's role, actions and services in the market. See a draft version to this here:
http://www.healthbusinessconsult.com/blog/customer-focus-in-pharma-22/

Scooped by Andrew Spong
Scoop.it!

More data, better drugs: Genentech, PatientsLikeMe ink groundbreaking research pact

More data, better drugs: Genentech, PatientsLikeMe ink groundbreaking research pact | Pharma | Scoop.it
The five-year agreement is the first broad research collaboration between PatientsLikeMe and a drug company, but it also demonstrates how open-source research and social media are increasingly tapped by companies to get real-world insights into diseases and how patients respond to treatments.
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Chats not charts: a three-step programme for pharmaceutical postmarketing

Chats not charts: a three-step programme for pharmaceutical postmarketing | Pharma | Scoop.it
The air of despondency that is descending over the pharmaceutical industry's use of social media is perverse. It has nothing to do with a putative (and also fictive) absence of interest on the pati...
more...
Anneliz Hannan's curator insight, April 1, 2014 5:15 AM

Andrew Spong wants  pharma to step up to the plate on pharma social media as the marketers they are. 

Scooped by Andrew Spong
Scoop.it!

Corporate digital IQ linked to performance

Corporate digital IQ linked to performance | Pharma | Scoop.it

PwC identifies five key capabilities that make a difference in raising a company's digital IQ.

 

They are:

 

Behavior 1: CEO actively champions digital

Behavior 2: Strong CIO-CMO relationship

Behavior 3: Outside-in approach to digital innovation

Behavior 4: Significant New IT Platform investments

Behavior 5: View digital as an enterprise capability  

 

Andrew Spong's insight:

Even the pharma companies who perform relatively (a loaded term) well in digital environments fail at least one of these criteria.

 

Most fail more than one.

 

Some fail all of them.

 

And: I'm probably being generous.

 

N.B. it goes without saying that 'significant new IT platform investment' need not correspond to measurable improvements across measures.

more...
Alexandre Gultzgoff's curator insight, April 1, 2014 11:07 AM

did they attend SPMSD LTA forum?

Scooped by Andrew Spong
Scoop.it!

Merck's big data healthcare collaborations seek insights for drug development

Merck's big data healthcare collaborations seek insights for drug development | Pharma | Scoop.it
Sachin Jain, the CMIO of Merck's digital health arm talks about big data health insights it hopes to gain from healthcare industry collaborations.
more...
Sven Awege's curator insight, March 11, 2014 5:46 AM

Another great initiative by Merck here. My question though is that the kinds of outcomes and insights we're talking about might be better managed by a more independent player! Not sure how comfortable patients are about being data-mined by a Pharma company.

Scooped by Andrew Spong
Scoop.it!

Five things big pharma can learn from the rare disease community

Five things big pharma can learn from the rare disease community | Pharma | Scoop.it

Companies in the rare disease space have learned lessons big pharma can use too:

 

1. Patient engagement starts in clinical trials

2. Silence isn't safe

3. Support must go beyond the brand

4. Don't wait for a crisis

5. True innovation begins with outcomes

Andrew Spong's insight:

A lovely piece by Wendy White from last week. Recommended.

more...
rob halkes's curator insight, March 6, 2014 4:35 AM

We can guide pharma to innovate, but they must implement it themselves .. ;-)

Gary Monk's curator insight, March 6, 2014 12:00 PM

Interesting article

MyHealthShare's curator insight, March 8, 2014 7:00 AM

Five things big pharma can learn from the rare disease community | http://myhealthshare.org @andrewspong http://sco.lt/...

Scooped by Andrew Spong
Scoop.it!

Mobile technologies in healthcare today

Mobile technologies in healthcare today | Pharma | Scoop.it
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

From beyond the pill to beyond the pixel: twelve digital health companies championed by Apple

Apple features 12 digital health products in its new iPhone 5s ad ranging from apps to track your work out to devices to analyze your form.
Andrew Spong's insight:

There have been many ongoing conversations about threats to pharma's visibility in digital environments emerging from outside the industry.

 

As hardware manufacturers align themselves with companies responsible for apps and peripherals compatible with their devices, another challenge to pharma's visibility and relevance in digital spaces has emerged.

 

 

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Successful mobile health apps: four determining factors

Successful mobile health apps: four determining factors | Pharma | Scoop.it

Mobile research firm research2guidance surveyed more than 2,000 developers and found some common traits among the successful mobile health apps:

 

Their revenue model is service-based, rather than based on paid downloads. More than a third of so-called successful apps, ranging from image sharing to sophisticated remote monitoring, get their revenue primarily from service sales, research2guidance said.

They integrate with other databases or health tracking devices. Open APIs allow apps to access more data that can enrich their value.

They have a large portfolio. More than one-third of the “successful” developers had published more than 20 mobile health apps, the firm said.

IOS is their No. 1 platform. A whopping three-fourths of successful developers had a preference for iOS over Android.

more...
ChemaCepeda's curator insight, May 20, 2014 5:34 AM

Añadiría otros factores que salieron en #eSaludCyL como la facilidad de uso y la motivación para su utilización a largo plazo

Rowan Norrie's curator insight, May 21, 2014 6:30 AM

Excellent article highlighting key facts about the mobile health sector, with link to free report.

Scooped by Andrew Spong
Scoop.it!

Samsung the pharmaceutical company, and the coming changes in rheumatoid and psoriatic arthritis

Samsung the pharmaceutical company, and the coming changes in rheumatoid and psoriatic arthritis | Pharma | Scoop.it

In 2016, Samsung will be the first consumer technology company to enter the pharmaceutical marketplace with a biosimilar version of Amgen's moderate to severe rheumatoid arthritis and psoriatic arthritis treatment, Enbrel.

 

If this thought doesn’t focus legacy pharmaceutical companies into throwing everything they have into reforming themselves as social business, nothing will. The survival of even the largest companies is far from certain when giants such as Samsung have set their sights upon entering the industry.

 

Samsung doesn’t think like a pharmaceutical company.

 

Pharmaceutical companies better start thinking like Samsung.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Samsung, the pharma company: biopharm investments; first biosimilars in 2016

Samsung, the pharma company: biopharm investments; first biosimilars in 2016 | Pharma | Scoop.it

South Korea’s biggest company is investing at least $2 billion in biopharmaceuticals, including the growing segment of biosimilars, which are cheaper versions of brand-name biotechnology drugs that have lost patent protection.

 

Samsung, with $327 billion annual revenue, aims to become a major force in biotechnology, an industry expected to generate sales of more than $220 billion in five years. With the electronics market reaching saturation, billionaire chairman Lee Kun Hee has been investing in new areas that might shore up growth for the family-controlled company.

 

Samsung plans to sell its first biosimilar version of Amgen Inc. (AMGN)’s arthritis therapy Enbrel in 2016 in Europe and a version of Johnson & Johnson (JNJ)’s Remicade treatment for autoimmune diseases in 2017, according to Ko. A separate unit called Samsung Biologics Co. has contracts to manufacture biologic medicines for branded pharmaceutica

Andrew Spong's insight:

For me, this is the biggest health story of the year so far.

 

With Samsung's dominance in the mobile market and its focus on integrating health into its products, there can be little doubt that the company has the potential to make a huge impression on the future of healthcare.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Corporate Communications should not be implementing pharma's social media

Corporate Communications should not be implementing pharma's social media | Pharma | Scoop.it
Corporate Communications is fine for implementing social media for investor relations but patients and caregivers want someone who can keep it real and speak to them with respect, transparency and honesty.
Andrew Spong's insight:

Aside from corporate reporting, I whole-heartedly agree with Rich on this.

 

Clearly, pretty much the opposite is the case at present, and the longer the status quo is preserved, the harder it will be for the industry to break away from a decision which use and familiarity have legitimated over time, and which is looking less and less viable.

 

Social media sits for the most part in pharma corporate communications because it's the easiest thing to do, not because it's the right thing to do.

more...
Tanja Juslin's curator insight, May 15, 2014 4:13 AM

Challenges seen both when corporate communication is doing what they "technically" know best and when therapy area specialist would know the area best, it's not clear that they can "technically" manage this.

Scooped by Andrew Spong
Scoop.it!

Merck's EHR alliance to improve patient health

Merck's EHR alliance to improve patient health | Pharma | Scoop.it

In one of its first digital health initiatives, Merck has partnered with web-based electronic health record provider Practice Fusion to help doctors track the percentage of their adult patients who are up to date on their vaccines.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

"The question of pharma's social ROI has gone the way of the question of the shape of the planet"

"The question of pharma's social ROI has gone the way of the question of the shape of the planet" | Pharma | Scoop.it

Mark Senak writes in his Eye on FDA blog:

 

"The question of ROI [in pharma's use of social media] has gone the way of the question of the shape of the planet.


It may still be worth having the discussion if for no other reason than to actually get grounded in your goals and objectives.  But in fact, we have all moved on and we are not turning back.


It is probably as much good to ask what the ROI is on social media in the same way you might ask what the ROI was on your press releases, your web site, or the electronic socket in wall.


In the end, it may not be a question about the return on investment as much as the cost of not doing business."

Andrew Spong's insight:

Nicely put.

more...
José Manuel Taboada's curator insight, April 17, 2014 5:22 AM

So the cuestion may be to be or not to be in Social.

Scooped by Andrew Spong
Scoop.it!

More than three-quarters of patients think pharma companies have a responsibility to provide information and services that help patients manage their own health

More than three-quarters of patients think pharma companies have a responsibility to provide information and services that help patients manage their own health | Pharma | Scoop.it

More than three-quarters (76 percent) of patients think pharmaceutical companies have a responsibility to provide information and services that help patients manage their own health.

 

Nearly as many respondents, 74 percent, indicated that the most appropriate time to initiate outreach is when they start making a medication, although half of the respondents are open to receiving assistance after they have begun a course of treatment or are considering switching.

 

The report also indicated that patients are generally very satisfied with patient services when they get them—and are willing to give more personal health information to obtain more relevant services.

 

Of the patients who receive services, a sizable majority (70 to 80 percent) express satisfaction with all the services used.

 

In addition, patients appear to place high importance on services, providing a strong indication that services are viewed as a "should offer" not a "nice to offer" add-on—dependent on the type of medicine or treatment.

 

Patients are also ready and willing to share information in order to receive improved or free services, the survey found.

 

Eighty percent of patients are proactively seeking information about the medicines they are taking, and more than 70 percent seek out information on health care services related to their conditions.

 

Nearly four in 10 (38 percent) want pharmaceutical companies to reach them through social media—a significantly higher percentage than what they want from physicians, pharmacists, friends and family.

 

"There is a clear need for pharmaceutical companies to understand patient communication preferences and customize channels and content to provide relevant customer experiences at scale," the report said.

 


more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

So we have gone digital; what next?

So we have gone digital; what next? | Pharma | Scoop.it
The digital wave is here to stay, but how well are marketers riding it? A global IBM C-suite study has some interesting insights
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Effective pharma-patient interaction requires credible representation within communities

Effective pharma-patient interaction requires credible representation within communities | Pharma | Scoop.it

Every year, the board game community BoardGameGeek (BGG)  holds an annual convention called BGG.con. It’s pretty much paradise for US unplugged gamers: a library of over 3,500 titles, round-the-clock sessions, vendors, and more.

 

BGG.con is usually held in at the Hyatt Regency Dallas Fort Worth International Airport hotel.

 

Meet Glenn...

more...
No comment yet.
Rescooped by Andrew Spong from Digital Health
Scoop.it!

"I want to build a healthcare community..."

"I want to build a healthcare community..." | Pharma | Scoop.it
The immortal phrase that should bring everyone out in a sweat; whether client side or agency side. Building an online community is one of the hardest things to do, not simply in healthcare. It needs considerable investment, time, research, and also a little bit of luck. 

Via Alex Butler
more...
Mira Alison's curator insight, March 11, 2014 3:40 AM

Of course you have a website now. Make sure that your web pages are loaded with your main keywords, so that they have a natural flow of content . Also make sure that the word can be found somewhere in the titles ( at least your top three )Once you have that all set up , make sure that you have set up the links to those pages through the site pages on the Internet.Read for more information:

http://cuxtomizedfatloss.blogspot.com/p/fat-misfortune-extreme-methodology-to.html
Dr Martin Wale's curator insight, March 14, 2014 4:53 AM

So much to do...

Vigisys's curator insight, March 15, 2014 6:58 AM

Une communauté c'est bien, un réseau de soins numérique c'est mieux, mais le challenge est encore plus grand ! C'est ce à quoi nous nous adressons avec nos projets Indesir.fr et vigidiab.fr. 

Scooped by Andrew Spong
Scoop.it!

Social media as a research tool in patient behaviour patterns

Social media as a research tool in patient behaviour patterns | Pharma | Scoop.it

Social media in healthcare is most often used to reach out to patients and encourage them to be active, but one research team is taking it to a whole new level by using websites such as Facebook and Twitter to actually conduct research and compile data. The Boston Children’s Hospital and Merck have joined forces to use social media as a tool to better understand insomnia.

 

By using data from Twitter such as tweet content and time, as well as Facebook login times and comments, researchers hope to create a “portrait” of a patient’s daily activities and active times. As Health IT Analyticsexplains, “If the patient is complaining of sleeplessness at three in the morning, for example, when his daily routine requires him to be at work by 9 a.m., the researchers will be able to flag him as a likely candidate for follow-up from a primary care provider.”

more...
No comment yet.